Managing Expectations and Realistic Timelines It is important to remember that weight loss is a marathon, not a sprint
Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders
Many required new drugs, from intravenous chemotherapy to medications that would temporarily stop the heart so surgery could be conducted
Semaglutide shows promise as a potential alcohol use disorder medication Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse
One measure of subjectively estimated tiredness also improved
Varicose vein treatment can vary depending on the type of varicose veins, the severity of symptoms, and the patients overall health